Brief: Mayne Pharma Group Updates On FIRB Approval
16/10/2025 05:26
Oct 16 (Reuters) - Mayne Pharma Group Ltd MYX.AX: UPDATE ON FIRB APPROVAL FIRB DECISION ON MAYNE PHARMA ACQUISITION DELAYED DECISION EXPECTED PRIOR TO 31 OCTOBER 2025 REFERS TO PROPOSED ACQUISITION BY COSETTE VIA SCHEME OF ARRANGEMENT Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)